Multidisciplinary team awarded grant to test novel treatments for prostate cancer

July 3, 2014

Drs. Christina Addison and Jim Dimitroulakos have received $280,000 to identify new biomarkers and to test the efficacy of novel treatments in patient-derived prostate tumor tissues. The grant from the Prostate Cancer Fight Foundation in partnership with the Telus Ride for Dad will support research activities of a multidisciplinary team of investigators that includes basic scientists, oncologists, urologists and pathologists. The team will tackle many of the critical issues facing patients with prostate cancer such as better predicting whether a cancer will metastasize, spread or recur; improve outcomes among established prostate cancer treatments; and optimize treatments for patients who have the most aggressive form of prostate cancer. The end goal is to better predict the risk of a patient having aggressive or resistant prostate cancer and personalize treatment for those patients.

About the Ottawa Hospital Research Institute
The Ottawa Hospital Research Institute (OHRI) is the research arm of The Ottawa Hospital and is an affiliated institute of the University of Ottawa, closely associated with the university’s Faculties of Medicine and Health Sciences. OHRI includes more than 1,700 scientists, clinical investigators, graduate students, postdoctoral fellows and staff conducting research to improve the understanding, prevention, diagnosis and treatment of human disease.

Media contact
Paddy Moore
Communications and Public Relations
Ottawa Hospital Research Institute
613-737-8899 x73687
613-323-5680 (cell)